TGFB1 and metastatic malignant neoplasm: Our results indicate, for the first time, that simultaneous abrogation of TGFβ and BMP signaling pathways by systemic administration of the naturally derived TGFβ/BMP dual inhibitor could result in substantially reduced tumor growth, invasion and metastasis in TNBC and other metastatic cancer types.